🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Receiving a diagnosis of acute hepatic #porphyria (#AHP) was a life-altering moment for Hannah, who felt separated by her "future" and "past" selves. But, a diagnosis also allowed her to begin to move forward. Learn more about Hannah’s AHP story expressed through dance.

This morning, we reported 1st Quarter 2025 financial results and key updates. Join our LIVE webcast TODAY at 8:30 am ET or catch the replay later: bit.ly/374c75E Read the full press release: bit.ly/3GubcmD #RNAi #RNAiTherapeutics #siRNA

As we reflect on a strong start to the year, our Chief Human Resources Officer, Melissa McLaughlin, explains how culture is more than a value statement — it’s a competitive advantage. #ChallengeAccepted #RNAi #Leadership #CompanyCulture

Women’s pain is often dismissed, delaying diagnosis of serious conditions like Donna’s acute hepatic #porphyria (AHP), which took 10+ years. Recognizing seemingly unrelated symptoms can help AHP patients regain control.

For U.S. Audiences: Helping your loved one navigate primary #hyperoxaluria type 1 (PH1) can be a difficult journey. Learn about PH1 from pediatric nephrologist Dr. Stone as she discusses this #RareDisease and an FDA-approved treatment option.

Our CEO, Dr. Yvonne Greenstreet has again been named one of Boston Magazine’s Most Influential Bostonians for 2025! From advancing RNAi science to her work with outside organizations, her influence extends beyond the lab. #Leadership #Biotech #RNAi #WomenInSTEM #BostonLeaders

We believe all patients, regardless of their diagnosis, have the potential to benefit from the promise that #RNAiTherapeutics hold to #SilenceDisease and #AmplifyLife. That’s why we’ve pioneered this innovative approach and are working to bring it to as many patients as possible.

May is International #HuntingtonsDisease Awareness Month, described as like having ALS, Parkinson's and Alzheimer's – at the same time. There are many ways to get involved in advocacy, including through the HDSA Team Hope Walk: bit.ly/4moZLNB #LetsTalkAboutHD

Ahead of #GlobalPorphyriaDay, sisters Sue and Liz of British Porphyria Association remind us why awareness, genetic testing and proactive care are essential for people living with #porphryia. GlobalPorphyria

Thank you to our manufacturing partner, Sharp Services, for honoring a visit from an ATTR amyloidosis with cardiomyopathy patient and everyone in the TTR community by planting a tree on their campus in Allentown PA. Together, we'll keep patients at the center of everything we do.

At #HeartFailure2025 we shared new data from the HELIOS-B study showing reductions in risk of all-cause mortality and key indicators of disease progression in patients with ATTR #amyloidosis with cardiomyopathy (#ATTR-CM). Explore the details 👇 #HFA_ESC

Today is #GlobalPorphyriaDay (GPD)! Our teams around the world went #PurpleforPorphyria—standing with GlobalPorphyria and the global porphyria community to raise awareness and continue driving progress for this #raredisease. Learn more about #GPD: bit.ly/39ZW4u4

We’re proud to be ranked in the top 20 on Boston Business Journal’s inaugural list of the Largest Massachusetts-Headquartered Manufacturers! Early investment in local #manufacturing has helped strengthen our global supply chain and leadership delivering #RNAi therapeutics to patients.

We’re proud to share our 2024 Corporate Responsibility Report, highlighting how we’re working to create a healthier, more equitable world through health equity, employee empowerment, and environmental sustainability. #CorporateResponsibility #CSR #ESG #Sustainability

It was a busy #HeartFailure2025. Missed the conference? Learn more about the design of the Phase 3 trial to evaluate our next-generation TTR silencer for patients with ATTR amyloidosis with cardiomyopathy (#ATTR-CM) and the new data from across our TTR franchise below. #HFA_ESC

Living with disease is noisy. The sounds of doctor visits, tests, managing medication, and declining things you want to do can mute the joy of life. But what happens when disease is silenced? #SilenceDisease #AmplifyLife #RNAi #RNAiTherapeutics

At Alnylam, we put patients at the center of all we do. Grateful to the #ATTR-CM patient who recently shared their powerful story with our manufacturing partner, Thermo Fisher Scientific – and thank you to the team for partnering with us to listen, collaborate, and drive impact.

Our 2024 Corporate Responsibility Report shows how Alnylam is making an impact. We support patients and employees, advance science, uplift communities, and protect the planet. Our work reflects our values and ambition to give back to society. #CorporateResponsibility #CSR #ESG

Living an amplified life with disease means your disease doesn’t dominate your day-to-day, allowing you to focus on doing what you love with the people who matter most. Helping people get to that place is why we’ve pioneered #RNAiTherapeutics. #SilenceDisease #AmplifyLife

Throughout May, Alnylam celebrated Asian American and Pacific Islander Heritage Month with workshops, a Holi Festival and a gala honoring AAPI culture and leadership. We also partnered with AsianWomenForHealth for their CelebrAsians Gala highlighting local advocacy. #AANHPIHeritageMOnth